Antiplatelet Activity of Tetramethylpyrazine via Regulation of the P2Y12 Receptor Downstream Signaling Pathway. [PDF]
Guan B, Gao J, Tan Y, Ma X, Shi D.
europepmc +1 more source
Discordance in tests used to detect inhibition of the P2Y12 receptor in patients undergoing interventional neuroradiology procedures. [PDF]
Gegri M +4 more
europepmc +1 more source
Postoperative Bleeding Risk after Gastric Endoscopic Submucosal Dissection in Patients Receiving a P2Y12 Receptor Antagonist. [PDF]
Hirai R +11 more
europepmc +1 more source
The P2Y12 Receptor Antagonist Selatogrel Dissolves Preformed Platelet Thrombi In Vivo. [PDF]
Crescence L +7 more
europepmc +1 more source
P2Y12 Receptor Antagonists and Morphine: A Dangerous Liaison?
P2Y12 receptor antagonists, concurrently administered with aspirin in what has come to be commonly called dual antiplatelet therapy, are a mainstay of treatment for patients with acute coronary syndromes.
Deftereos, S. +5 more
core +1 more source
Increased expression of the P2Y12 receptor is involved in the failure of autogenous arteriovenous fistula caused by stenosis. [PDF]
Liu L, Gao J, Tang Y, Guo G, Gan H.
europepmc +1 more source
Clopidogrel, an ADP-P2Y12 Receptor Antagonist, Is Associated With Lower Opioid Consumption and a Reduced Incidence of Delirium in Cancer Patients Receiving Chemotherapy: A Nationwide Retrospective Cohort Study in Japan. [PDF]
Abe H +9 more
europepmc +1 more source
Evidence for a PI3-kinase independent pathway in the regulation of Rap1b activation downstream of the P2Y12 receptor in platelets. [PDF]
Dangelmaier C, Kunapuli SP.
europepmc +1 more source
Response to letter: "The effect of P2Y12 receptor inhibitors on clinical outcomes in patients with acute coronary syndrome undergoing PCI and receiving abciximab". [PDF]
Altınkaya O, Aydemir S, Özkoç M.
europepmc +1 more source

